Alloxazine
Alloxazine is a selective A2b antagonist. Alloxazine completely block 5’N-Ethylcarboxamido adenosine (NECA) -mediated cyclic AMP accumulation with an IC50 of 2.9 μM. Alloxazine can be used for the research of cancer[1][2].
Product Specifications
CAS Number
490-59-5
Product Name Alternative
Isoalloxazine
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Adenosine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/alloxazine.html
Purity
99.46
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1)N=C2NC3=CC=CC=C3N=C2C1=O
Molecular Formula
C10H6N4O2
Molecular Weight
214.18
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Brackett LE, Daly JW. Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts. Biochem Pharmacol. 1994 Mar 2;47 (5) :801-14.|[2]Shin HK, et al. Role of adenosine A (2B) receptors in vasodilation of rat pial artery and cerebral blood flow autoregulation. Am J Physiol Heart Circ Physiol. 2000 Feb;278 (2) :H339-44.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH032258-01 10 µg
Recombinant Human CLEC4E/Mincel Protein (His Tag)
Sign In for Pricing
View Details PKSH032258-02 50 µg
Recombinant Human CLEC4E/Mincel Protein (His Tag)
Sign In for Pricing
View Details 
BNC402742-500 1x 500 µL
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details